SP096STUDY ON MUTATIONS OF CHINESE PATIENTS WITH LIPOPROTEIN GLOMERULOPATHY
Yang Mingxin,Pan Xiaoxia,Liu Yunzi,Shi Manman,Yu Xialian,Xu Jing,Li Xiao,Shen Pingyan,Zhang Wen,Ren Hong,Xie Jingyuan,Chen Nan
DOI: https://doi.org/10.1093/ndt/gfy104.sp096
IF: 7.1857
2018-01-01
Nephrology Dialysis Transplantation
Abstract:INTRODUCTION AND AIMS: Lipoprotein glomerulopathy(LPG)is a unique and rare disorder of renal lipidosis.It is characterized by lipoprotein thrombi in glomeruli.LPG was found to be due to mutations of the APOE gene.15novel APOE variants have been identified to date.Three types of APOE mutation have been detected in China: APOE Maebashi (142Arg-144Leu-0),APOE Kyoto (Arg25-Cys) ,and APOE Guangzhou (Arg150-Pro) .In this study, we report on 5 Chinese patients with biopsyproven lipoprotein glomerulopathy (LPG) investigated for clinical manifestations, pathological characteristics and apolipoprotein E (apoE) genetic analysis.METHODS: A retrospective analysis of the clinical and pathological features was made in 5 patients with biopsy-proven LPG.Genetic analysis of apoE were completed.RESULTS: 5 patients within 5 unrelated Han families were enrolled in this study, consisting of 4 male patients and 1 female patient, which from Jiangxi Province, Zhejiang Province, Hubei Province, Guizhou Province respectively.Age at onset varied from 16 to 42 years.3 patients had a family history.The median urine protein was 8.4[0.13-9.9]g/24h,while the mean eGFR was 102.5626.5ml/min/1.73m 2 and 3 patients(60%)presented with microscopic hematuria and hypertension.As for blood lipids,the mean serum apoE was 4.4461.04mg/dl(1patients presented with increased serum apoE levels while the apoE level of others were normal).TG 1.760.6mmol/L,TC5.3161.21mmol/L,LDL3.6661.35mmol/L,HDL1.0560.18mmol/L.lightmicroscope of Kidney biopsy showed dilated capillary lumina filled with amorphous pale-staining thrombus-like substances.Immunofluorescence shows that apoE and apoB were present primarily in the capillary lumina.The apoE Osaka/Kurashiki mutation (R158P) was detected in 2 patients, with e3/ e3 ande3/e4 genotypes respectively.The APOE Kyoto mutation (p.Arg25Cys) was detected in 3 patients, with e3/e3(2 patients) ande3/e4(1 patients) genotypes respectively.One patient with apoE Osaka/Kurashiki was diagnosed of IgA nephropathy .Compared with APOE Kyoto, patients with apoE Osaka/Kurashiki showed higher blood pressure (SBP 158.561.5 vs 111.763.5mmHg,p¼0.05;DBP 10662 vs 68.363mmHg, p¼0.015).Furthermore, although not statistically significant, patients with apoE Osaka/Kurashiki showed more urine protein(9.15vs 1.43g/24h,p¼0.08),higherTC(6.2060.16vs 4.716 1.24mmol/L,p¼0.28),andlower GFR(83.2610.5 vs 115.3626.1 ml/min/1.73m2,p¼0.29).Patients treated with statins/fibrates and ARBs, while 2 of them received plasma exchange / lipid absorption therapy.At 2-12 months of follow-up, eGFR of 4 patients had improved which of 1 patient decreased.Proteinuria of 2 patients was significantly improved.CONCLUSIONS: The apoE Osaka/Kurashiki mutation (R158P) was detected in Chinese for the first time.Compared with APOE Kyoto,patients with apoE Osaka/ Kurashiki seems to be more serious.In addition, only 1 patient presented with higher plasma apoE, which needs to be further clarified.